Intracranial pressure increases during alfentanil-induced rigidity

Area of Science:

• Anesthesiology
• Neuroscience
• Pharmacology

Background:

• Intracranial pressure (ICP) management is critical in neuroanesthesia.
• Opioid analgesics are frequently used in anesthetic protocols.
• Potential side effects of opioids on ICP require careful consideration.

Purpose of the Study:

• To investigate the effect of alfentanil-induced rigidity on intracranial pressure (ICP) in a rat model.
• To determine the relationship between somatic rigidity and hemodynamic changes during alfentanil administration.
• To provide insights into anesthetic management strategies for patients with elevated ICP.

Main Methods:

• Rats underwent surgical implantation of arterial, central venous, and subdural cannulae.
• Mechanical ventilation was employed to maintain normocarbia.
• Alfentanil was administered intravenously during emergence from halothane anesthesia.
• Intracranial pressure (ICP) and central venous pressure (CVP) were monitored.

Main Results:

• Rats developing alfentanil-induced somatic rigidity exhibited significant increases in ICP (7.5 +/- 1.0 mmHg) and CVP (5.9 +/- 1.3 mmHg).
• These pressure elevations returned to baseline upon abolition of rigidity with metocurine.
• Rats not exhibiting rigidity showed no significant changes in ICP or CVP.

Conclusions:

• Alfentanil-induced rigidity is associated with a significant rise in intracranial pressure (ICP).
• Preventing rigidity is essential when using alfentanil or similar opioids in patients with compromised ICP.
• These findings have implications for anesthetic management in neurosurgical patients.